As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...
SurvivorNet on MSN
'Mo-Rez,' a developing ovarian cancer drug, outperforms current standards with 60% response rates, offering first real hope in years
Early data show the cancer drug mocertatug rezetecan (Mo‑Rez) delivering response rates above 60% in patients with ovarian ...
Aortic aneurysms are characterized by abnormal enlargement of the aorta, the primary artery responsible for carrying blood ...
The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.
PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...
For patients with metastatic pancreatic cancer, new treatment options are urgently needed to increase survival time and ...
Herbal medicines and naturally derived metabolites are increasingly recognized for their potential in managing and treating ...
Salk scientists have created a platform to study mitochondrial DNA mutations that lead or contribute to human disease, and ...
Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...
Explore the latest statistics on cutaneous melanoma: why incidence rates are rising by 1.2% annually while mortality is ...
Fi Novelist Who Disappeared for Decades In “What We Are Seeking,” the cult author Cameron Reed returns to show us a strange, ...
You are a mutant. You were born with around 100 mutations that your parents don’t have. You’ll pass about half of these on to your children, if you have any, who will have 100 new mutations of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results